Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Family-Accommodating Snow Sports Experiences- Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
- Cocoa Prices Settle Lower on Expectations of Adequate Supplies
- Careful Connections: Building Association and Trust
- Shrewd Home Gadgets to Save Energy
- Instructions to Pick the Right Dental Expert for Teeth Substitution
- Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- Historic underwater structure discovered by divers off French coast
